This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1846 and based in Ewing, NJ , Church & Dwight Co., Inc. develops, manufactures and markets a broad range of household, personal care and specialty products. It is the leading U.S. producer of sodium bicarbonate, popularly known as baking soda, a natural product that cleans, deodorized, leavens and buffers. The company operates in six countries (Canada, Mexico, U.K., France, Australia and Brazil) and exports to over 90 other countries. Approximately 17% of the company’s net sales came from outside the U.S. in 2019. The company has 12 key brands, including ARM & HAMMER, Trojan, OxiClean, Spinbrush, First Response, Nair, Orajel, Xtra, L’IL CRITTERS and VITAFUSION, Waterpik, FLAWLESS and Batiste. The company’s ARM & HAMMER brand is one of the nation’s most trusted trademarks for a broad range of consumer and specialty products and its products are sold under ARM & HAMMER liquid and powder laundry detergent, ARM & HAMMER cat litter, ARM & HAMMER dental care and ARM & HAMMER baking soda. Markedly, eleven out twelve power brands were acquired by the company and added to its portfolio since 2001.
Altria Gears Up for Q4 Earnings: Here's What You Should Understand
by Zacks Equity Research
MO's Q4 results are likely to reflect gains from pricing actions and strength in NJOY and on! amid shifting consumer preferences.
Sysco Set to Release Q2 Earnings: Should You Expect a Beat This Time?
by Zacks Equity Research
SYY's Q2 results are likely to reflect gains from Food-Away-From-Home sector along with improved efficiency and supply-chain productivity.
Church & Dwight (CHD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kimberly-Clark Set to Release Q4 Earnings: Should You Expect a Beat?
by Zacks Equity Research
KMB's Q4 results are likely to reflect a challenging consumer environment with soft demand, retail inventory reductions and currency risks.
Beat the Market the Zacks Way: Fiserv, 3M, Intrusion in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
McCormick Set to Release Q4 Earnings: Should You Expect a Beat?
by Zacks Equity Research
MKC's Q4 results are likely to reflect improved volume trends, though high SG&A costs are likely to have dampened profits.
Procter & Gamble Stock: A Buy Opportunity Before Q2 Earnings?
by Rajani Lohia
PG's Q2 results should benefit from brand strength and solid strategies, offset by issues in Greater China, geopolitical tensions and currency volatility.
Will Church & Dwight (CHD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Church & Dwight (CHD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Tilray Brands, Inc. (TLRY) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Tilray Brands (TLRY) delivered earnings and revenue surprises of -150% and 3.33%, respectively, for the quarter ended November 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Church & Dwight Stock a Buy, Hold or Sell at a 28.2X P/E Multiple?
by Zacks Equity Research
CHD is well-positioned for long-term growth, with a strong portfolio of trusted brands despite headwinds from shifting consumer spending patterns.
Here's Why Church & Dwight (CHD) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
National Vision (EYE) Down 4.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Church & Dwight Trades Near 52-Week High: Is It Worth Your Investment?
by Zacks Equity Research
CHD is poised for growth, supported by strong demand, resilient brands and new product success, despite headwinds from shifting consumer spending patterns.
Why Church & Dwight (CHD) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PG's Premium P/E Valuation: Value Opportunity or Risky Proposition?
by Rajani Lohia
While Procter & Gamble's near-term outlook suggests challenges due to ongoing tensions, its strategies and execution indicate long-term growth potential.
Company News for Nov 4, 2024
by Zacks Equity Research
Companies in The News Are: XOM,CVX,CAH,CHD
CHD Q3 Earnings Beat, Robust Consumer Demand Drives Sales Growth
by Zacks Equity Research
Church & Dwight's Q3 results reflect increased sales and earnings on strong consumer demand, resilience of its brands and successful new product launches.
Church & Dwight (CHD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Church & Dwight (CHD) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Church & Dwight (CHD) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 16.18% and 1.12%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Clorox (CLX) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 36.76% and 8.13%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Church & Dwight to Report Q3 Earnings: Here's What You Should Know
by Zacks Equity Research
CHD's robust brand equity, commitment to innovation and new products set it up for a decent Q3 sales result despite a challenging consumer spending landscape.
Unveiling Church & Dwight (CHD) Q3 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Church & Dwight (CHD) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Earnings Preview: Church & Dwight (CHD) Q3 Earnings Expected to Decline
by Zacks Equity Research
Church & Dwight (CHD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive
by Zacks Equity Research
Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive are part of the Zacks top Analyst Blog.
The Zacks Analyst Blog Highlights Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive
by Zacks Equity Research
Procter & Gamble, Clorox, Church & Dwight and Colgate-Palmolive are part of the Zacks top Analyst Blog.